Author:
Schneider Sophie,Alezra Eric,Yacoub Mokrane,Ducharme Océane,Gerard Emilie,Dutriaux Caroline,Prey Sorilla
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Dermatology,Oncology
Reference6 articles.
1. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.;Long;Lancet Oncol,2018
2. Immune-related adverse events (irAEs): diagnosis, management, and clinical pearls.;Darnell;Curr Oncol Rep,2020
3. Potential immune-related adverse events associated with monotherapy and combination therapy of ipilimumab, nivolumab, and pembrolizumab for advanced melanoma: a systematic review and meta-analysis.;Almutairi;Front Oncol,2020
4. Two cases of nonbacterial cystitis associated with nivolumab, the anti-programmed-death-receptor-1 inhibitor.;Shimatani;Urol Case Rep,2018
5. A case of cystitis after administration of nivolumab.;Ozaki;Int Cancer Conf J,2017
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献